CXCL12 and diabetes mellitus: To summarize, EET improve deteriorated wound healing in diabetes: first, by enhancing neoangiogenesis, especially in the early phase of wound healing; second, by contributing to dissolution of the initial inflammatory reaction allowing the crucial transition from inflammatory to proliferative phase in wound healing; and third, by enhanced homing via SDF-1α expression.